Polaris Partners
Polaris Partners is an investment firm that invests in healthcare and biotechnology companies.
Business Model: B2B
Revenue: $7.8M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Polaris Partners Information
Geographic Data
Address: One Marina Park Drive
City: Boston
State: MA
Zip: 02210
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$1B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
6,074,838Website Global Rank
1,063Website Monthly Traffic
Twitter Followers
Description
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies&s; care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics, and genomics.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2010 | Stickybits | Seed Round | 300k |
| 11/2013 | Adcade | Series A | 5M |
| 1/2021 | B2Gnow | Venture Round | - |
| 6/2007 | Ultreo | Series C | 11.3M |
| 12/2020 | Automotive Titling Company | Venture Round | - |
| 2/2012 | RetireOne | Venture Round | 4M |
| 3/1999 | Sentillion | Series A | 2.7M |
| 9/2011 | Arsenal Medical | Debt Financing | 3M |
| 6/2015 | Arsenal Medical | Venture Round | 0 |
| 1/2017 | Incredible Foods | Venture Round | - |
| 3/2014 | Bitium | Series A | 6.5M |
| 5/1999 | Akamai Technologies | Series B | 0 |
| 6/2009 | Janssen Global Services | Series A | 15M |
| 10/2006 | Mintera | Series B | 10M |
| 12/1998 | Incentive Systems | Series B | 7.3M |
| 6/1998 | Incentive Systems | Series A | 2M |
| 1/2003 | Centive | Venture Round | 18M |
| 10/2017 | Baxter Planning | Corporate Round | 25M |
| 10/2016 | Iora Health | Series D | 75M |
| 5/2015 | Drizly | Series A | 0 |
| 2/2000 | eRealty.com | Venture Round | 10M |
| 10/2008 | e-Rewards | Private Equity Round | 60M |
| 11/2002 | PhyFlex Networks | Series B | 0 |
| 12/2006 | Cerulean Pharma | Venture Round | 2M |
| 4/2006 | Roundbox | Series B | 15M |
| 10/2008 | T2 Biosystems | Series B | 0 |
| 9/2009 | Ironwood Pharmaceuticals | Venture Round | 25M |
| 12/2015 | Mazlo | Venture Round | 10M |
| 12/2007 | SnappCloud | Series C | 8.7M |
| 7/2012 | Impinj | Debt | 21M |
| 3/2007 | Transoma Medical | Series C | 13M |
| 9/2007 | Allux Medical | Series B | 7.5M |
| 7/2013 | aTyr Pharma | Series D | 49M |
| 7/2003 | Alnylam Pharmaceuticals | Private Equity Round | 24.6M |
| 10/2022 | Neumora Therapeutics | Series B | 0 |
| 2/2023 | Paratus Sciences | Series A | 0 |
| 6/2022 | Scholar Rock | Post-IPO Equity | 0 |
| 11/2005 | Nanosys | Series C | 0 |
| 1/2018 | Scholar Rock | Series C | 47M |
| 4/2008 | Imprivata | Series C | 15M |
| 2/2020 | Amagma Therapeutics | Series A | - |
| 4/2008 | Turbine | Series C | 40M |
| 3/2015 | Upland Localytics | Series D | 35M |
| 10/2007 | BlackArrow | Series B | 12M |
| 3/2008 | Adimab | Series B | 3.2M |
| 12/2014 | First Opinion | Series A | 6M |
| 12/2015 | Kallyope | Series A | 44M |
| 1/2006 | Athenix | Series C | 13M |
| 3/2015 | XANT | Series D | 60.6M |
| 10/2017 | Visterra | Series C | 0 |
| 3/2020 | Kallyope | Series C | 112M |
| 4/2003 | Acusphere | Funding Round | 0 |
| 2/2022 | Seismic Therapeutic | Series A | 0 |
| 3/2020 | Novi Connect | Seed Round | 1.5M |
| 5/2020 | Foresight Mental Health | Series A | - |
| 5/2014 | Jibe | Series C | 0 |
| 7/2012 | Logentries | Seed Round | 1.1M |
| 3/2009 | Veracode | Series C | 5M |
| 7/2018 | Ajax Health | Series B | 120M |
| 1/2018 | Pandion Therapeutics | Series A | 58M |
| 1/2004 | Athenix | Series B | 12.5M |
| 6/2001 | Avaki | Venture Round | 6M |
| 5/2010 | Phreesia | Series D | 16M |
| 10/2013 | NextCODE Health | Series A | 15M |
| 3/2011 | Message Bus | Series A | 0 |
| 10/2010 | 1366 Technologies | Series B | 0 |
| 7/2009 | Egnyte | Series A | 6M |
| 1/2019 | Dewpoint Therapeutics | Series A | 60M |
| 1/1998 | Advanced Inhalation Research | Venture Round | - |
| 3/2006 | Allux Medical | Venture Round | - |
| 5/2012 | Infinite Power Solutions | Series D | 10M |
| 2/2006 | Microbia | Series E | 75M |
| 10/2007 | Mintera | Series C | 0 |
| 4/2005 | Mintera | Series B | 18.5M |
| 4/2010 | Selecta Biosciences | Series C | 15M |
| 2/2011 | Arsanis | Series A | 10M |
| 8/2015 | Avitide | Series C | 7.6M |
| 6/2004 | Q1 Labs | Series C | 11M |
| 11/2003 | Q1 Labs | Series B | 14.4M |
| 4/2014 | Kala Pharmaceuticals | Series B | 0 |
| 9/2019 | Recurly | Series C | 19.5M |
| 3/2000 | Gizmoz | Venture Round | 0 |
| 3/2005 | Sirtris Pharmaceuticals | Series B | 27M |
| 3/2012 | Kala Pharmaceuticals | Private Equity Round | 7.2M |
| 2/2013 | Living Proof | Series C | 30M |
| 8/2020 | Freenome | Series C | 270M |
| 8/2011 | T2 Biosystems | Series D | 0 |
| 4/2017 | Lyndra Therapeutics | Series A | 0 |
| 10/2013 | 1366 Technologies | Series C | 0 |
| 9/2020 | Dewpoint Therapeutics | Series B | 0 |
| 12/2005 | LastPass | Series B | 10M |
| 12/2018 | Drizly | Series C | 34.6M |
| 9/2000 | Chiaro Networks | Series C | 100M |
| 9/2014 | Lob | Series A | 7M |
| 1/2014 | Suneva Medical | Series B | 20M |
| 10/2020 | Sonrai Security | Series B | 20M |
| 10/2010 | SiOnyx | Series B | 12.5M |
| 6/2021 | Faro | Series A | 15M |
| 5/2001 | Remon Medical Technologies | Series A | 10M |
| 2/2023 | Faro | Series A | 20M |
| 7/2009 | Cerulean Pharma | Series B | 10M |
| 2/2001 | ClearForest | Series B | 12M |
| 4/2007 | aTyr Pharma | Series B | 10.5M |
| 8/2021 | Jnana Therapeutics | Series B | 50M |
| 1/2009 | JibJab Bros Studios | Series C | 0 |
| 6/2015 | XTuit Pharmaceuticals | Series A | 22M |
| 11/2010 | Cerulean Pharma | Series C | 24M |
| 5/2011 | YourBio Health | Series A | 4.5M |
| 2/2014 | Upland Localytics | Series C | 16M |
| 12/2008 | Paratek | Venture Round | 20M |
| 12/2021 | Freenome | Series D | 300M |
| 5/2007 | Apnex Medical | Series A | 16.1M |
| 9/2014 | Scholar Rock | Series A | 20M |
| 1/2021 | IconOVir Bio | Series A | 0 |
| 7/2021 | ByHeart | Series B | 0 |
| 10/2014 | Recurly | Series B | 12M |
| 8/2015 | AgBiome | Series B | 0 |
| 4/2005 | MessageGate | Series B | 5M |
| 5/2014 | Vhoto | Seed Round | 750k |
| 5/2021 | August Bioservices | Series A | 23.6M |
| 11/2003 | Medvantx | Series C | 5M |
| 6/2021 | Thirty Madison | Series C | 0 |
| 3/2012 | Wantful | Series A | 5.5M |
| 11/2012 | Spindle | Venture Round | 2.3M |
| 7/2002 | Expresiv Technologies | Series A | 9.8M |
| 8/2020 | Podimetrics | Series B | 0 |
| 4/2010 | ShoeDazzle | Series B | 13M |
| 11/2003 | Zingdom Communications | Series B | 10M |
| 6/2021 | CubicPV | Venture Round | 0 |
| 4/2021 | Tectonic Therapeutic | Series A | 80M |
| 3/2007 | Ascend Health | Series B | 20.1M |
| 9/2019 | Faraday Pharmaceuticals | Series B | 25M |
| 9/2021 | Nomad Health | Series D | 0 |
| 12/2007 | EXOS | Series B | 5M |
| 1/2006 | Xpressdocs | Venture Round | - |
| 6/2002 | Zingdom Communications | Series A | 7.4M |
| 1/2004 | Research Now | Venture Round | - |
| 6/2014 | Navitor Pharmaceuticals | Series A | 23.5M |
| 6/2010 | Acceleron Pharma | Venture Round | 10.3M |
| 7/2019 | Kronos Bio | Series A | 105M |
| 10/2018 | Gauss Surgical | Series C | 0 |
| 5/2014 | Vhoto | Seed Round | 2.4M |
| 1/2006 | Heavy Inc. | Series D | 10M |
| 7/2004 | Impinj | Series C | 22M |
| 11/2009 | Sun Catalytix | Seed Round | 1M |
| 7/2012 | Space Monkey | Seed Round | 2.3M |
| 2/2020 | Montis Biosciences | Seed Round | 0 |
| 7/2021 | Muna Therapeutics | Series A | 0 |
| 4/2014 | XANT | Series C | 100M |
| 7/2016 | B12 | Series A | 12.4M |
| 10/2001 | Avaki | Series A | 10M |
| 12/2005 | Asthmatx | Series C | 27M |
| 7/2019 | Caledonia Spirits | Series B | 0 |
| 5/2005 | Imprivata | Series A | 4.5M |
| 2/2007 | PhyFlex Networks | Private Equity Round | 0 |
| 5/2021 | PathAI | Series C | 0 |
| 11/2006 | BridgePort Networks | Series C | 0 |
| 1/2016 | Alector | Series D | 29.5M |
| 1/2004 | PhyFlex Networks | Venture Round | 17.5M |
| 3/2003 | AudioAudit | Series A | 15M |
| 3/2007 | Hangout Industries | Series A | 6M |
| 6/2001 | Proficiency | Series C | 27.4M |
| 2/2002 | Nanosys | Series A | 15M |
| 11/2022 | Jnana Therapeutics | Series C | 0 |
| 2/2021 | Armorblox | Series B | 30M |
| 1/2016 | Syros Pharmaceuticals | Series C | 40M |
| 7/2021 | FloQast | Series D | 0 |
| 4/2013 | AgBiome | Series A | 17.5M |
| 1/2020 | Lyra Therapeutics | Series C | 0 |
| 9/2022 | Capstan Therapeutics | Series A | 102M |
| 4/2020 | Pandion Therapeutics | Series B | 80M |
| 12/2019 | OM1 | Series C | 50M |
| 7/2012 | BarkBox | Seed Round | 1.7M |
| 8/2007 | Adnexus | Series C | 15.5M |
| 2/2011 | Seamless Receipts | Venture Round | 0 |
| 6/2022 | Tessa Therapeutics | Series A | 0 |
| 9/2001 | Sentillion | Series C | 0 |
| 1/2001 | Sockeye Networks | Series A | 28M |
| 6/2008 | Wakonda Technologies | Series A | 3.2M |
| 4/2005 | Prospex Medical | Seed Round | 1.5M |
| 3/2008 | Hydra Biosciences | Series C | 34M |
| 3/2008 | Trevena | Series A | 24M |
| 3/2011 | BridgePoint Medical | Series C | 9.1M |
| 6/2018 | Metacrine | Series C | 65M |
| 4/2019 | Ajax Health | Series C | 85M |
| 3/2000 | Esurg.com | Series B | 20M |
| 9/2011 | turntable.fm | Series A | 7M |
| 7/2019 | Freenome | Series B | 160M |
| 12/2009 | Genocea Biosciences | Series B | 25.7M |
| 10/2012 | Genocea Biosciences | Series C | 30M |
| 6/2021 | Wellthy | Series B | 0 |
| 11/2014 | Novaerus | Venture Round | 10M |
| 1/2007 | Q1 Labs | Series D | 9M |
| 8/2003 | Archus Orthopedics | Series B | 18M |
| 3/2005 | Aepona | Series B | 20M |
| 10/2006 | EXOS | Series A | - |
| 8/2020 | Kronos Bio | Private Equity Round | 155M |
| 12/2020 | Folx Health | Seed Round | 4.4M |
| 3/2013 | T2 Biosystems | Series E | 40M |
| 5/2021 | Dyno Therapeutics | Series A | 100M |
| 2/2005 | Art.com | Venture Round | 30M |
| 10/2010 | aTyr Pharma | Series C | 23M |
| 6/2008 | ChipIn | Series B | 5M |
| 11/2009 | Fate Therapeutics | Series B | 30M |
| 11/2016 | Africa Healthcare Network | Venture Round | - |
| 3/2019 | Africa Healthcare Network | Series A | - |
| 12/2019 | 1366 Technologies | Series E | 0 |
| 7/2012 | EXOS | Venture Round | 22.5M |
| 5/2017 | Swiftly | Seed Round | 2.5M |
| 2/2008 | VKernel Corporation | Series A | 4.6M |
| 1/2020 | FloQast | Series C | 40M |
| 11/2009 | ShoeDazzle | Series A | 7M |
| 7/2011 | Lascaux | Seed Round | 600k |
| 11/2003 | The Center from Health Promotion | Venture Round | 10M |
| 5/2011 | Neuronetics | Series E | 30M |
| 3/2020 | Amunix | Series A | 0 |
| 4/2003 | Nanosys | Series B | 0 |
| 6/2006 | Adnexus | Series B | 27M |
| 10/2012 | Promedior | Series D | 0 |
| 2/2018 | Nomad Health | Series B | 12M |
| 8/2010 | Visterra | Debt Financing | 6M |
| 10/2014 | Visterra | Series B | 30M |
| 6/2010 | Follica | Series B | 7.5M |
| 8/2005 | Pervasis Therapeutics | Series B | 12.4M |
| 9/2012 | WikiCell Designs | Series A | 10M |
| 10/2006 | SiCortex | Series B | 21M |
| 9/2007 | Phreesia | Series B | 10.3M |
| 2/2006 | Imprivata | Series B | 12M |
| 8/2010 | Cardlytics | Series C | 18.5M |
| 12/2017 | Metacrine | Series B | 22M |
| 8/2009 | BridgePoint Medical | Venture Round | 6.1M |
| 1/2007 | BridgePoint Medical | Series B | 10M |
| 10/2009 | Alimera Sciences | Series C | 5M |
| 10/2014 | Syros Pharmaceuticals | Series B | 53M |
| 3/2013 | Janssen Global Services | Venture Round | 13.5M |
| 4/2011 | Janssen Global Services | Series B | 18.4M |
| 3/2012 | Promedior | Series D | 21.5M |
| 1/2011 | Genocea Biosciences | Series B | 35M |
| 3/2022 | TRex Bio | Series A | 0 |
| 2/2022 | Dewpoint Therapeutics | Series C | 0 |
| 6/2018 | Falkonry | Series A | 5M |
| 12/2019 | Allstacks | Seed Round | 0 |
| 12/2015 | Navitor Pharmaceuticals | Series B | 33M |
| 2/2021 | SpineZone | Series A | 12M |
| 6/2009 | Ocular Therapeutix | Series C | 15M |
| 8/2019 | Notarize | Series B | 0 |
| 5/2005 | Paratek | Series C | 15M |
| 4/2000 | Sentillion | Series B | 8.8M |
| 5/2012 | PostRocket | Seed Round | 610k |
| 12/2004 | TechTarget | Series C | 15M |
| 3/2014 | Boxever | Series A | 6M |
| 12/1999 | ICplanet | Series A | 8.7M |
| 3/2010 | Formspring | Series A | 2.5M |
| 3/2004 | Cardiac Dimensions | Series C | 15M |
| 3/2010 | Jibe | Seed Round | 875k |
| 1/2008 | HealthCentral | Post-IPO Equity | 50M |
| 9/1999 | Soapstone Networks | Series C | 40M |
| 6/2015 | SQZ Biotech | Series A | 5M |
| 9/2006 | WHI Solution | Venture Round | 0 |
| 2/2016 | Notarize | Seed Round | 2.4M |
| 1/2019 | Wellthy | Series A | 5.1M |
| 11/2013 | Lob | Seed Round | 0 |
| 5/2006 | Promedior | Series A | 0 |
| 6/2017 | Neuronetics | Series G | 0 |
| 8/2014 | YourBio Health | Series B | 16M |
| 7/2018 | Pointy | Series B | 12M |
| 6/2021 | Kojin Therapeutics | Series A | 60M |
| 1/2009 | Hydra Biosciences | Series D | 22M |
| 5/2018 | CAMP4 Therapeutics | Series A | 30M |
| 1/2013 | Art.com | Series C | 6.2M |
| 4/2004 | Earth Networks | Series B | 23M |
| 2/2007 | Aepona | Series C | 10M |
| 1/2010 | Free &a; Clear | Venture Round | 10M |
| 12/2016 | Qstream | Series B | 15M |
| 11/2012 | Visterra | Series A | 26.1M |
| 3/2009 | GI Dynamics | Series C | 0 |
| 2/2001 | PhyFlex Networks | Series A | 0 |
| 6/2021 | Cyclerion Therapeutics | Post-IPO Equity | 0 |
| 9/2014 | Qualaroo | Venture Round | 7.3M |
| 4/2005 | Integrian | Series B | 13M |
| 9/2001 | Athenix | Series A | 8M |
| 7/2000 | Partnerware | Series B | 32M |
| 5/2008 | GreenFuel | Series C | 13.9M |
| 3/2021 | Tausight | Series A | 20M |
| 12/1997 | Endius | Series B | 0 |
| 12/2004 | Sirtris Pharmaceuticals | Series A | 13M |
| 6/2016 | Visterra | Series C | 23.1M |
| 3/2006 | CodeRyte | Series C | 0 |
| 9/2012 | Upland Localytics | Series B | 5.5M |
| 4/1998 | Soapstone Networks | Series B | 0 |
| 5/2004 | GI Dynamics | Series B | 0 |
| 4/2020 | ByHeart | Series A | 0 |
| 9/2004 | SiCortex | Series A | 21M |
| 9/2013 | Arsanis | Series B | 20M |
| 2/2005 | Frictionless Commerce | Venture Round | 0 |
| 9/2004 | Ember | Venture Round | 25M |
| 10/2002 | Ember | Series B | 20M |
| 6/2006 | Ember | Series C | 12M |
| 1/1997 | Aspect Medical Systems | Venture Round | 17.5M |
| 6/2004 | TechTarget | Series B | 70M |
| 1/2002 | Matrics | Series B | 0 |
| 8/2018 | Twistlock | Series C | 33M |
| 5/2002 | Advion Inc. | Series B | 15M |
| 2/2013 | Kala Pharmaceuticals | Series A | 0 |
| 10/2005 | Transoma Medical | Series B | 12.7M |
| 9/2016 | SQZ Biotech | Series B | 16M |
| 12/2013 | Egnyte | Series D | 0 |
| 6/2008 | Thing Labs | Series A | 1.6M |
| 7/2002 | Silicon Optix | Series B | 17M |
| 6/2021 | Lyndra Therapeutics | Series C | 0 |
| 2/2012 | Apnex Medical | Series C | 20M |
| 11/2006 | BlackArrow | Series B | 14.8M |
| 1/2004 | Paratek | Series B | 15M |
| 8/1997 | Soapstone Networks | Series A | 15.8M |
| 7/2000 | StoreRunner | Venture Round | - |
| 2/2017 | Voysis | Series A | 8M |
| 4/2013 | Bluetrain.io | Seed Round | 1.5M |
| 3/2004 | Momenta Pharmaceuticals | Series C | 20.5M |
| 6/2022 | Nomad Health | Venture Round | 0 |
| 12/2019 | Podimetrics | Series B | 3.1M |
| 6/2017 | Avitide | Equity | 12M |
| 1/2010 | MicroCHIPS | Venture Round | 16.5M |
| 9/2018 | Morphic Therapeutic | Series B | 0 |
| 6/2010 | BIND Therapeutics | Series C | 12.4M |
| 5/2020 | SQZ Biotech | Series D | 0 |
| 2/2009 | Selecta Biosciences | Series B | 15.1M |
| 4/2009 | Ember | Venture Round | 8M |
| 4/2012 | Adimab | Venture Round | 14M |
| 1/2004 | mValent | Series B | 9M |
| 7/2022 | Auron Therapeutics | Series A | 0 |
| 6/2014 | Profitero | Series A | 8M |
| 12/2022 | August Bioservices | Series B | 0 |
| 3/2004 | WeatherBug | Series B | 23M |
| 8/2007 | Avila Therapeutics | Series A | - |
| 10/2012 | docTrackr | Seed Round | 2M |
| 12/2000 | PacketLight | Series A | 18M |
| 6/2015 | Kissmetrics | Series B | 3M |
| 5/2001 | eRealty.com | Series B | 15M |
| 6/2022 | Foresight Mental Health | Series C | - |
| 11/2020 | Satellite Bio | Seed | 19M |
| 6/2021 | CAMP4 Therapeutics | Series A | 0 |
| 5/2009 | Hangout Industries | Series B | 4M |
| 1/2000 | Linguateq | Venture Round | 7.8M |
| 4/2015 | Neuronetics | Series F | 0 |
| 2/2006 | Archivas | Series C | 12M |
| 10/2005 | Automattic | Series A | 0 |
| 9/2005 | Biolex Therapeutics | Series B | 36M |
| 5/2007 | Biolex Therapeutics | Series C | 30M |
| 3/2003 | Adnexus | Series A | 13M |
| 4/2000 | goRefer.com | Series A | 0 |
| 8/2009 | Pervasis Therapeutics | Series C | 17.4M |
| 4/2005 | Digital Safety Technologies | Venture Round | 41.1M |
| 3/2003 | Silicon Optix | Series B | 27M |
| 2/2000 | CapitalStream | Venture Round | 18M |
| 10/2002 | CapitalStream | Private Equity Round | 10M |
| 11/2003 | Saegis Pharmaceuticals | Series B | 30M |
| 5/2017 | Swiftly | Venture Round | 0 |
| 1/2007 | Veracode | Series B | 19.5M |
| 6/2015 | 480 Biomedical | Series C | 0 |
| 5/2009 | VKernel Corporation | Series B | 7M |
| 9/2007 | Arsenal Medical | Series B | 13.1M |
| 10/2020 | Primmune Therapeutics | Series A | 0 |
| 9/2009 | aTyr Pharma | Series C | 12M |
| 1/2010 | Quantcast | Series C | 31.6M |
| 9/2006 | Infinite Power Solutions | Venture Round | 34.7M |
| 12/2008 | Infinite Power Solutions | Series B | 13M |
| 7/2018 | Simon Data | Series B | 20M |
| 5/2018 | Iora Health | Series E | 100M |
| 8/2019 | Simon Data | Series C | 30M |
| 12/2020 | Noema Pharma | Series A | 60M |
| 5/2023 | Larkspur Biosciences | Series A | 0 |
| 10/2010 | Sun Catalytix | Series B | 9.5M |
| 10/2016 | Cityworks | Venture Round | 14.5M |
| 1/2012 | Recurly | Series A | 6M |
| 3/2006 | Veracode | Series A | 7.5M |
| 2/2017 | Falkonry | Seed Round | 6.3M |
| 7/2020 | Vico Therapeutics | Series A | 31M |
| 8/2015 | Metacrine | Series A | 36M |
| 11/2014 | AgBiome | Venture Round | 0 |
| 8/2002 | Midstream Technologies | Series C | 26M |
| 8/2011 | Pulmatrix | Series B | 14M |
| 3/2001 | Midstream Technologies | Series B | 16M |
| 6/2015 | Pulmatrix | Post-IPO Equity | 10M |
| 11/2009 | Pulmatrix | Series B | 30.2M |
| 3/2013 | Receptos | Series B | 30M |
| 3/2021 | EGenesis | Series C | 0 |
| 2/2022 | Kallyope | Series D | 0 |
| 1/2016 | Scholar Rock | Series B | 36M |
| 2/2017 | Drizly | Series B | 17M |
| 5/2008 | Sprout | Series B | 5M |
| 1/2005 | Remon Medical Technologies | Series C | 0 |
| 7/2013 | Kissmetrics | Series B | 7M |
| 12/2005 | Impinj | Series D | 26.5M |
| 9/2008 | Lolapps | Series A | 4M |
| 6/2005 | Centive | Venture Round | 10M |
| 3/2013 | US HealthVest | Series A | 0 |
| 8/2010 | Infinite Power Solutions | Series C | 20M |
| 11/2007 | Dataupia | Series B | 16M |
| 12/2010 | 1366 Technologies | Series B | 0 |
| 7/2017 | Compass Therapeutics, Inc. | Series A | - |
| 2/2018 | Quentis | Series A | 48M |
| 8/2006 | Acceleron Pharma | Series B | 30M |
| 1/2004 | Hydra Biosciences | Series B | 0 |
| 11/2007 | Fate Therapeutics | Series A | 12M |
| 12/2017 | Jnana Therapeutics | Series A | 50M |
| 12/2008 | Roundbox | Series C | 20M |
| 2/2000 | Accordant Health Services | Venture Round | 14M |
| 2/2010 | 1366 Technologies | Series A | 6.2M |
| 11/2008 | Adimab | Series C | 4M |
| 9/2015 | Selecta Biosciences | Series E | 38M |
| 10/2014 | Selecta Biosciences | Private Equity Round | 20M |
| 1/2011 | CatchFree | Series A | 5.5M |
| 7/2021 | OM1 | Series D | 85M |
| 9/2010 | Phreesia | Series D | 20M |
| 2/2009 | Phreesia | Series C | 11.6M |
| 8/2017 | Freenome | Series A | 7M |
| 9/2004 | Silicon Optix | Series C | 40M |
| 10/2008 | Respicardia | Series B | 0 |
| 10/2021 | Sonrai Security | Series C | 0 |
| 8/2015 | Editas Medicine | Series B | 0 |
| 1/2011 | Ocular Therapeutix | Series C | 6M |
| 7/2022 | CAMP4 Therapeutics | Series B | 0 |
| 2/2013 | Jibe | Series B | 10M |
| 7/2002 | Hydra Biosciences | Series A | 9.3M |
| 9/2020 | Neogene Therapeutics | Series A | 110M |
| 10/2007 | Acceleron Pharma | Series C | 31M |
| 1/2008 | Cerulean Pharma | Series B | 8.1M |
| 10/2022 | Folx Health | Series B | 0 |
| 6/2017 | FloQast | Series B | 25M |
| 5/2021 | Hummingbird Bioscience | Series C | 0 |
| 2/2019 | Lyndra Therapeutics | Series B | 0 |
| 8/2020 | Thirty Madison | Series B | 47M |
| 10/2005 | GlycoFi Inc. | Series C | 11M |
| 11/2005 | Alimera Sciences | Series B | 31.8M |
| 11/2020 | Adagio Therapeutics | Series B | 0 |
| 4/2016 | Quartet Health | Series B | 40M |
| 4/2015 | CliQr Technologies | Series C | 0 |
| 7/2020 | Adagio Therapeutics | Series A | 0 |
| 12/2012 | Cerulean Pharma | Private Equity Round | 13M |
| 4/2013 | Iora Health | Series B | 14M |
| 3/2008 | Alimera Sciences | Series C | 30M |
| 10/2021 | Neumora Therapeutics | Series A | 0 |
| 1/2018 | Quartet Health | Series C | 45M |
| 3/2007 | Impinj | Series E | 19M |
| 3/2007 | Microbia | Series F | 50M |
| 6/2019 | Quartet Health | Series D | 0 |
| 1/2017 | XANT | Series D | 0 |
| 5/2021 | Akili Interactive Labs | Series D | 0 |
| 12/2005 | mValent | Venture Round | 6M |
| 4/2021 | Cohere Health | Series B | 36.1M |
| 3/2022 | Podimetrics | Series C | 0 |
| 5/2020 | Dyno Therapeutics | Seed Round | 9M |
| 8/2018 | SQZ Biotech | Series C | 0 |
| 9/2015 | Alector | Series C | 32M |
| 11/2021 | Ankyra | Series B | 45M |
| 4/2021 | Adagio Therapeutics | Series C | 0 |
| 6/2019 | BlackThorn Therapeutics | Series B | 76M |
| 3/2023 | Volastra Therapeutics | Series A | 0 |
| 2/2018 | Kallyope | Series B | 66M |
| 12/2020 | Sesh | Seed Round | 3.5M |
| 11/2016 | TalkIQ | Seed Round | 7M |
| 2/1999 | Internet Brands | Venture Round | - |
| 7/2009 | Experience, Inc. | Venture Round | 4.5M |
| 9/2016 | Sofregen Medical | Series A | 6.2M |
| 9/2020 | ARinsights | Venture Round | - |
| 12/2004 | Pervasis Therapeutics | Series A | 2M |
| 7/2000 | ICplanet | Venture Round | 4.5M |
| 11/2019 | Cardurion Pharmaceuticals | Series A | - |
| 1/2008 | Pervasis Therapeutics | Venture Round | 9.8M |
| 1/2000 | Experience, Inc. | Venture Round | - |
| 12/2017 | Janssen Global Services | Series B | 25M |
| 4/2000 | OpenReach | Series B | 15M |
| 3/2007 | LegalZoom | Series A | 45M |
| 4/2010 | BlackArrow | Series C | 0 |
| 12/2004 | BlackArrow | Series A | 6M |
| 2/2008 | Visterra | Seed Round | 2M |
| 1/1997 | Data Sciences International | Venture Round | - |
| 1/2021 | Tectonic Therapeutic | Seed Round | - |
| 12/1999 | Esurg.com | Series A | - |
| 1/2010 | Adimab | Series D | 8.2M |
| 8/2014 | Strata Health | Venture Round | - |
| 5/2010 | Stickybits | Series A | 1.6M |
| 9/2017 | Suono Bio | Seed Round | - |
| 6/2012 | Vets First Choice | Venture Round | 0 |
| 4/2016 | Kala Pharmaceuticals | Series C | 68M |
| 6/2002 | Convoq | Series A | 7.4M |
| 10/2010 | FREEjit | Series A | - |
| 6/2023 | Candesant Biomedical | Series B | 35M |
| 10/2020 | FidoCure | Series A | 0 |
| 1/2008 | ice | Venture Round | 47M |
| 5/2017 | Lob | Series B | 22.9M |
| 2/2010 | Allurent | Venture Round | 2M |
| 6/2002 | Cardiac Dimensions | Series B | 12M |
| 3/2009 | Pulmatrix | Series A | 3.5M |
| 11/2018 | ClearSky Data | Equity | 20M |
| 12/2003 | Turbine | Series A | 18M |
| 11/2014 | WellAir | Venture Round | 10M |
| 11/2010 | Follica | Series B | 135k |
| 6/2011 | ReadyForZero | Series A | 4.5M |
| 1/2008 | Quantcast | Series B | 20M |
| 7/2003 | Matrics | Series C | 20M |
| 10/2007 | JibJab Bros Studios | Series B | 3M |
| 8/2008 | Follica | Series B | 11M |
| 8/2001 | Ember | Seed Round | 3M |
| 5/2011 | Fate Therapeutics | Series B | 36M |
| 3/2021 | Amunix | Series B | 117M |
| 1/1997 | Allaire Corporation | Seed Round | - |
| 5/2021 | Engine Biosciences | Series A | 0 |
| 2/2008 | PublicEarth | Series A | 3M |
| 2/2002 | Transoma Medical | Series A | 12M |
| 2/2020 | Volastra Therapeutics | Seed | 12M |
| 11/2021 | Be Me Health | Seed Round | 7M |
| 8/2008 | Living Proof | Series A | 7M |
| 8/2016 | Bitium | Venture Round | 0 |
| 5/2011 | ShoeDazzle | Series C | 40M |
| 4/2013 | BarkBox | Series A | 5M |
| 3/2000 | WHI Solution | Venture Round | 0 |
| 2/2011 | Ocular Therapeutix | Series D | 14M |
| 7/2010 | Recurly | Seed Round | 1.6M |
| 6/2010 | Aepona | Series C | 10M |
| 12/2011 | Cerulean Pharma | Series D | 15M |
| 7/2008 | Athenix | Series D | 10M |
| 11/2013 | Editas Medicine | Series A | 43M |
| 11/2008 | CodeRyte | Series D | 0 |
| 5/2009 | Visterra | Seed Round | 3.3M |
| 5/2005 | Turbine | Series B | 30M |
| 5/2003 | Momenta Pharmaceuticals | Series B | 19M |
| 6/2019 | Ajax Health | Series C | 15M |
| 1/2000 | Quintessent Communications | Series C | 15M |
| 7/2010 | Trevena | Series B | 35M |
| 8/2019 | Nomad Health | Series C | 34M |
| 2/2010 | Allux Medical | Series C | 2M |
| 4/2002 | Imprivata | Series A | 13.5M |
| 12/2006 | Heavy Inc. | Series E | 12.8M |
| 12/2002 | eRealty.com | Series D | 5M |
| 1/2008 | Automattic | Series B | 29.5M |
| 9/2008 | Transoma Medical | Series D | 5M |
| 3/2001 | TechTarget | Series A | 0 |
| 5/2018 | OM1 | Series B | 21M |
| 5/2018 | Profitero | Venture Round | 10M |
| 6/2016 | Morphic Therapeutic | Series A | 0 |
| 10/2021 | Cardurion Pharmaceuticals | Series B | 300M |
| 11/2007 | Allurent | Series B | 7.5M |
| 6/2003 | eRealty.com | Series E | 3M |
| 3/2004 | Pervasis Therapeutics | Seed Round | 500k |
| 6/2003 | GI Dynamics | Series A | 4.1M |
| 1/2011 | Useful Networks | Venture Round | - |
| 8/2006 | Confluence Technologies | Private Equity Round | 60M |
| 7/2007 | Adimab | Series A | 6.2M |
| 3/2008 | 1366 Technologies | Series A | 12.4M |
| 5/2006 | LRN | Series B | - |
| 12/2007 | Ultreo | Series C | 18.3M |
| 8/2003 | MessageGate | Series A | 5.1M |
| 9/2007 | Adimab | Series A | 5.9M |
| 6/2018 | NetRate Systems | Venture Round | - |
| 6/2000 | promoOrder.com | Venture Round | 6.4M |
| 2/2023 | Faro Health | Series A | 0 |
| 1/2006 | Convoq | Series C | 13M |
| 5/2010 | Arsenal Medical | Venture Round | 10M |
| 9/2013 | Logentries | Series A | 10M |
| 2/2000 | Ucentric Systems | Series A | 10M |
| 6/2015 | SimplyInsured | Series A | 5.9M |
| 6/2006 | JibJab Bros Studios | Series A | 6.4M |
| 12/2003 | Ucentric Systems | Venture Round | 4M |
| 1/2016 | Boxever | Series B | 12M |
| 2/2006 | Asempra Technologies | Series B | 20M |
| 12/2003 | Asempra Technologies | Series A | 9M |
| 5/2002 | Microbia | Series C | 25.3M |
| 10/2015 | Janssen Global Services | Venture Round | 32M |
| 3/2000 | Incentive Systems | Series C | 0 |
| 11/2003 | Convoq | Series B | 10M |
| 1/2010 | InSeal Medical | Seed Round | - |
| 1/2008 | Tempo Pharmaceuticals | Series B | 8.1M |
| 4/2014 | TRG Screen | Venture Round | - |
| 2/2021 | Folx Health | Series A | 25M |
| 10/2011 | 480 Biomedical | Series A | 15M |
| 2/2019 | KenSci | Series B | 22M |
| 12/2007 | Cardiac Dimensions | Series D | 0 |
| 5/2005 | Life Line Screening | Private Equity Round | - |
| 4/2002 | 170 Systems | Series A | 14M |
| 4/2000 | 3PLex.com | Series B | 15M |
| 2/2020 | Iora Health | Series F | 126M |
| 2/2000 | eSupportNow | Venture Round | 11.5M |
| 6/2016 | US HealthVest | Series B | 50M |
| 3/2015 | Quartet Health | Series A | 7M |
| 1/2015 | Iora Health | Series C | 0 |
| 1/2019 | Sonrai Security | Series A | 18.5M |
| 10/2013 | Alector | Series A | - |
| 4/2013 | RetireOne | Venture Round | 650k |
| 7/2018 | Gossamer Bio | Series B | 0 |
| 6/2008 | MarkMonitor | Series E | 24.4M |
| 5/2007 | Solace Pharmaceuticals | Series A | 15M |
| 11/2009 | Focus Financial Partners | Venture Round | 50M |
| 6/2002 | Incentive Systems | Series E | 2.5M |
| 3/2017 | Freenome | Series A | 65M |
| 10/2013 | Genuity Science | Series A | 15M |
| 1/2014 | WellAir | Venture Round | - |
| 1/2004 | Silicon Optix | Series B | 0 |
| 6/2012 | YourBio Health | Series A | 10M |
| 1/2021 | Auron Therapeutics | Seed Round | 0 |
| 2/2007 | BIND Therapeutics | Series A | 2.5M |
| 12/2009 | Apnex Medical | Series B | 14M |
| 1/1996 | Solidworks | Venture Round | - |
| 12/2004 | Archivas | Series B | 10M |
| 1/1997 | Classifieds2000 | Seed Round | - |
| 6/2001 | Incentive Systems | Series D | 18M |
| 1/2015 | Arsia Therapeutics | Seed Round | - |
| 8/2008 | PartsSource inc. | Venture Round | - |
| 7/2004 | Alimera Sciences | Series A | 26.8M |
| 11/2002 | Sockeye Networks | Series B | 12M |
| 7/2011 | DigiCert | Venture Round | - |
| 5/2010 | T2 Biosystems | Series C | 0 |
| 10/2012 | TopFloor | Venture Round | 6M |
| 1/2006 | T2 Biosystems | Series A | 5.5M |
| 4/2008 | Modelinia | Series A | 5M |
| 7/2018 | Alector | Series E | 133M |
| 4/2017 | Arsanis | Series D | 0 |
| 1/2017 | NDVR | Seed Round | - |
| 10/2016 | Genomics Medicine Ireland | Series A | 40M |
| 1/2002 | Transform Pharmaceuticals | Venture Round | - |
| 1/1999 | e-Rewards | Venture Round | 0 |
| 3/2023 | EpiBiologics | Series A | 0 |
| 1/2006 | Zingdom Communications | Series C | 13M |
| 11/2016 | YourBio Health | Series C | 10M |
| 1/2010 | Phytel | Venture Round | 14.2M |
| 3/2016 | FloQast | Series A | 6.5M |
| 7/2012 | BalconyTV | Series A | 750k |
| 7/2003 | Archivas | Series A | 6M |
| 12/2013 | Visterra | Series A | 8.1M |
| 5/2007 | Cerulean Pharma | Series A | 12.1M |
| 4/2019 | Cyclerion Therapeutics | Post-IPO Equity | 175M |
| 3/2015 | KinDex Pharmaceuticals | Series A | 5.5M |
| 2/2009 | Genocea Biosciences | Series A | 23M |
| 1/2008 | ARPU | Series C | 8.7M |
| 10/2009 | Thing Labs | Series A | 2.1M |
| 3/2020 | Notarize | Series C | 35M |
| 1/2021 | Covetrus | Seed Round | - |
| 2/2003 | Avaki | Series A | 4.2M |
| 4/2004 | Art.com | Series A | 20M |
| 8/2020 | Keeps | Series B | 47M |
| 9/2004 | BridgePort Networks | Series B | 25M |
| 5/2020 | Ankyra | Seed Round | 14.5M |
| 4/2017 | Twistlock | Series B | 17M |
| 10/2017 | KSQ Therapeutics | Series B | 76M |
| 4/2021 | Volastra Therapeutics | Seed | 32M |
| 9/2018 | KSQ Therapeutics | Series C | 80M |
| 5/2002 | Impinj | Series F | 14M |
| 7/2018 | AgBiome | Series C | 0 |
| 12/2018 | Kallyope | Series B | 21M |
| 11/2007 | BIND Therapeutics | Series B | 16M |
| 7/2014 | Faraday Pharmaceuticals | Series A | - |
| 1/2014 | Suneva Medical | Debt Financing | 15M |
| 12/2000 | Circe Biomedical | Private Equity Round | 28M |
| 2/2020 | Mesodyne | Pre Seed Round | 170k |
| 7/2012 | Egnyte | Series C | 16M |
| 11/2000 | Microbia | Series B | 0 |
| 7/2006 | ARPU | Series B | 5M |
| 3/2011 | Sosh | Seed Round | 1M |
| 11/2015 | ClearSky Data | Series B | 27M |
| 1/2004 | BridgePort Networks | Series A | 10M |
| 3/2023 | Noema Pharma | Series B | 0 |
| 10/2001 | Nanosys | Seed Round | 1.7M |
| 8/2010 | Respicardia | Series C | 0 |
| 9/2004 | Remon Medical Technologies | Series C | 16M |
| 5/2011 | Jibe | Series A | 6M |
| 1/2006 | Archus Orthopedics | Series C | 35M |
| 1/2016 | Morphic Therapeutic | Seed Round | 3M |
| 6/2006 | BridgePoint Medical | Series A | 1M |
| 7/2015 | Arivale | Series B | 36M |
| 2/2019 | Candesant Biomedical | Venture Round | 9.1M |
| 12/2019 | SQZ Biotech | Series D | - |
| 3/2011 | Living Proof | Series B | 16M |
| 1/2009 | Vyne | Venture Round | - |
| 5/2023 | Larkspur Biosciences | Series A | 0 |
| 3/2023 | EpiBiologics | Series A | 0 |
| 3/2023 | Volastra Therapeutics | Series A | 0 |
| 3/2023 | Noema Pharma | Series B | 0 |
| 2/2023 | Paratus Sciences | Series A | 0 |
| 2/2023 | Faro Health | Series A | 0 |
| 12/2022 | August Bioservices | Series B | 0 |
| 11/2022 | Jnana Therapeutics | Series C | 0 |
| 10/2022 | Folx Health | Series B | 0 |
| 10/2022 | Neumora Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
